Literature DB >> 30398472

Brain metastasis DNA methylomes, a novel resource for the identification of biological and clinical features.

Matthew P Salomon1, Javier I J Orozco1, James S Wilmott2, Parvinder Hothi3, Ayla O Manughian-Peter1, Charles S Cobbs3, Richard A Scolyer2,4,5, Dave S B Hoon1, Diego M Marzese1.   

Abstract

Brain metastases (BM) are one the most lethal and poorly managed clinical complications in cancer patients. These secondary tumors represent the most common intracranial neoplasm in adults, most frequently originating from lung cancer, breast cancer, and cutaneous melanoma. In primary brain tumors, such as gliomas, recent advances in DNA methylation profiling have allowed for a comprehensive molecular classification. Such data provide prognostic information, in addition to helping predict patient response to specific systemic therapies. However, epigenetic alterations of metastatic brain tumors with specific biological and translational relevance still require much further exploration. Using the widely employed Illumina Infinium HumanMethylation 450K platform, we have generated a cohort of genome-wide DNA methylomes from ninety-six needle-dissected BM specimens from patients with lung cancer, breast cancer, and cutaneous melanoma with clinical, pathological, and demographic annotations. This resource offers an unprecedented and unique opportunity to identify novel DNA methylation features influencing the behavior of brain metastasis, and thus accelerate the discovery of BM-specific theranostic epigenetic alterations.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30398472      PMCID: PMC6219670          DOI: 10.1038/sdata.2018.245

Source DB:  PubMed          Journal:  Sci Data        ISSN: 2052-4463            Impact factor:   6.444


Background & Summary

Patients diagnosed with brain metastasis (BM) have a poor quality of life and a dismal prognosis, with survival ranging from three to 25 months[1,2]. While developments in systemic drug treatments have significantly improved the survival of patients with extracranial metastases, BM lesions have shown limited response rates to these approaches[3]. This trend, along with improvements in neuro-diagnostic imaging techniques, has resulted in an increased incidence of metastatic brain tumors[4]. In large epidemiological studies, 8–10% of patients with solid tumors develop BM, this number increases up to 26% when brain autopsy studies are performed[5-9]. In fact, BM represents the most common intracranial neoplasm in adults, outnumbering even primary brain tumors. Interestingly, reflecting an organotropic behavior of tumor cells, the vast majority of secondary brain neoplasms (75-90%) are originated in patients with lung cancer, breast cancer, and cutaneous melanoma[5-8]. Genomic and epigenomic landscapes of primary brain tumors have been extensively investigated. In gliomas, for example, the cytosine-guanine island (CGI) methylator phenotype (CIMP) is frequently found in patients with lower grade gliomas harboring mutations on the IDH1 gene and is significantly associated with a better overall prognosis[10]. Additially, a favorable response to the DNA alkylating antineoplastic agent, temozolomide, has been directly connected to high DNA methylation (DNAm) level in the promoter region of the MGMT gene[11]. DNAm profiling has recently been shown to have the potential to accurately stratify primary central nervous system (CNS) tumours[12] and to significantly improve the diagnosis of cancer of unknown primary[13]. These clinically relevant findings have demonstrated DNAm profiling to be a valuable tool in the histomolecular evaluation of brain tumors[14,15]. Yet, while genomic and transcriptomic characterization has been performed to some extent[16], clinically relevant epigenetic alterations of metastatic brain tumors are still poorly understood. Therefore, given this significant knowledge gap, we constructed a comprehensive dataset that can be used to accelerate the identification of novel DNAm features with biological and clinical relevance for the three most frequent types of BM. Here, we present a dataset including genome-wide DNA methylomes constructed using Illumina Infinium HumanMethylation 450K BeadChips (HM450K) of 96 micro-dissected BM specimens from patients with breast cancer, lung cancer, and cutaneous melanoma (Fig. 1). In addition to DNAm data, this report provides a detailed description of the methodological approaches for patient selection, compliance matters, tissue processing and DNA preparation, data normalization, bioinformatics analyses, and usage notes including clinical and demographic information for all patients in the study. Seven of these patients are part of a cohort study that we previously analyzed to identify genome-wide DNAm variations during cutaneous melanoma progression to BM[17-20]. Therefore, the current cohort of BM DNA methylomes is composed of HM450K profiles included in two different NCBI’s Gene Expression Omnibus (GEO) datasets (GSE108576 and GSE44661). We believe that these datasets offer a unique opportunity for the discovery of novel diagnostic and prognostic biomarkers, while simultaneously providing insight into the underlying biology of this serious clinical complication. In this regard, we have employed these data to further explore the utility of DNAm profiles to accurately discriminate between primary and metastatic brain tumors, identify the origin of the BM lesions, and specifically classify BCBM into therapeutically relevant molecular subtypes[21]. Thus, we generated and validated a three-steps BM DNAm based classifier named "BrainMETH"[21].
Figure 1

Study design for the construction of genome-wide DNA methylation profiles of metastatic brain tumors.

(a) Patients with metastatic brain tumors from breast cancer, lung cancer or cutaneous melanoma origin were selected for the study. (b) A representative magnetic resonance imaging (MRI) scan of a single metastatic brain tumor lesion used as part of the clinical diagnosis is shown in the scheme. (c) After surgery, resected tumors were routinely stored as formalin-fixed and paraffin-embedded (FFPE) tissue blocks and stained with hematoxylin and eosin (H&E) for anatomic pathology diagnosis. (d) FFPE tissue sections underwent routine immunohistochemistry (IHC) evaluation to confirm the tumor of origin and molecular subtypes of each case. (e) After tumor cell-rich areas were identified, tissue microdissection followed by DNA purification was performed in each case. (f) DNA specimens passing the quality control metrics were converted with sodium bisulfite, enzymatically fragmented, and hybridized in the HM450K BeadChips. Raw intensity data were normalized and corrected β values for each specimen were generated. A representative heat map of the DNA methylation data is shown in the study scheme.

Methods

Tissue specimen collection

A total of 96 metastatic brain formalin-fixed paraffin-embedded (FFPE) tumor samples from 94 patients diagnosed with breast cancer BM (BCBM; n = 30), lung cancer BM (LCBM; n = 22), and cutaneous melanoma BMs (MBM; n = 44) were included in this study. Two breast cancer patients presented synchronous or asynchronous multiple lesions. The clinical and demographic characteristics of the patients included in the study have been summarized according to relevant information for each cancer type (Table 1). All patient-derived samples and clinical and demographic data were collected under research protocols approved by the joint Institutional Review Board of Providence Saint John’s Health Center/John Wayne Cancer Institute, the Western Institutional Review Board, the Institutional Review Board of Swedish Medical Center, and the Sydney Local Health District (Royal Prince Alfred Hospital Zone) Human Ethics Review Committee. All patients signed an informed consent before joining the study. The experiments were performed in accordance with the World Medical Association Declaration of Helsinki and the National Institutes of Health Belmont Report. Tissues were de-identified and coded according to recommendations of the Health Insurance Portability and Accountability Act (HIPAA) to ensure confidentiality of the patients.
Table 1

Clinical-demographic characteristics of patients with brain metastasis.

 BCBMLCBMMBMTotal BM
N28224494
Age (years)
 Median54.567.558.4561.35
 IQR19.751020.9019.81
 Range35-7943-8832-8232-88
Gender
 Female28 (100%)18 (81.8%)12 (27.27%)58 (61.7%)
 Male04 (18.2%)32 (72.73%)36 (38.3%)
Cancer Specific Subtypes
 HR+/HER2-: 12 (42.86%)NSCLC: 19 (86.4%)BRAF mut: 19 (43.19%) 
 HR any/HER2+: 11 (39.28%)SCLC: 3 (13.6%)NRAS mut: 18 (40.91%) 
 HR-/HER2-: 5 (17.86%) BRAF/NRAS wt: 5 (11.36%) 
   N/A: 2 (4.54%) 

Histopathological classification of brain metastasis

The BCBM specimens were classified into molecular subtypes according to the expression status of the hormone receptors (HR), i.e. estrogen receptor (ER) and progesterone receptor (PgR), and the human epidermal growth factor receptor 2 (HER2). ER and PgR were assessed by immunohistochemistry (IHC), and HER2 by IHC and/or in situ hybridization assays (ISH). FFPE tissue slides were sectioned at 4 μm, mounted onto plus-coated glass slides, and immunohistochemically stained using a Ventana BenchMark ULTRA automated slide stainer (Roche Diagnostics, Indianapolis, IN, USA) by the Clinical Laboratory Improvement Amendments (CLIA)-certified Department of Pathology, Providence Saint John’s Health Center, accredited by the College of American Pathologists (CAP). The antibodies used in this evaluation were the CONFIRM anti-Estrogen Receptor (SP1, #790-4324, Ventana Medical Systems, Tucson, AZ, USA), the CONFIRM anti-Progesterone Receptor (1E2, #790-2223, Ventana Medical Systems, Tucson, AZ, USA), and the PATHWAY anti-HER-2/neu (4B5, #790-2991, Ventana Medical Systems, Tucson, AZ, USA). The scoring criteria for these biomarkers were based on the current ASCO/CAP guidelines[22,23]. Briefly, ER and PgR were considered positive if there was staining of the nucleus in at least ≥1% of tumor cells in the sample. HER2 test result was considered positive if IHC 3+ (observed in a homogeneous and contiguous population and within >10% of the invasive tumor cells) or ISH amplified if single-probe average HER2 copy number >6.0 signals/cell or dual-probe HER2/CEP17 ratio ≥2.0. BCBM specimens were grouped according to the expression of these routinely evaluated markers into three therapeutically relevant subgroups: a- HR positive/HER2 negative, b- HR any/HER2 positive (HER2+), and c- HR negative/HER2 negative (aka triple-negative breast cancer; Table 1). The MBM samples were categorized according to the mutational status of BRAF and NRAS genes. Genomic DNA from MBM was amplified with standardized primers specific for exon 15 of BRAF, and exons 1 and 2 of NRAS[20]. Polymerase chain reaction (PCR) products were purified using QIAquick® PCR Purification Kit (#28106 Qiagen, Germany) and subsequently visualized in 2.2% agarose gel DNA cassettes for gel electrophoresis (FlashGel™ System, Lonza Inc, Rockland, ME, USA). Successfully amplified samples were then quantified by UV absorption spectrophotometry and sequenced using an internal primer[20] by Eurofins MWG Operon LCC (Eurofins Genomics LCC, Louisville, KY, USA). Sequencing results were analyzed using Chromas Lite v2.6.5 (Technelysium Pty Ltd, Australia) and mutations in NRAS and BRAF genes were annotated according to the Catalogue of Somatic Mutations in Cancer (COSMIC v86, Wellcome Sanger Institute, Cambridge, UK; http://cancer.sanger.ac.uk/cosmic)[24]. As the presence of BRAF and NRAS mutations were mutually exclusive events, the MBM specimens were classified into 3 categories: a- BRAF mutated, b- NRAS mutated, and c- BRAF/NRAS wild-type (Table 1). Due to limited tissue availability, two specimens were not profiled for oncogenic mutations on the BRAF or NRAS genes and presented in Tables 1 and 2 as not available (N/A).
Table 2

ISA-tab formatted table for the access of genome-wide DNA methylation and clinical-demographic data for each patient in the study

Sample NameSource nameCharacteristics[organism]Characteristics[organism part]Characteristics[sample type]Method [Protocol 1]Method [Protocol 2]Method [Protocol 3]Method [Protocol 4]Method [Protocol 5]Factor Value [Age at BM diagnosis (years)]Factor Value [Gender]Factor Value [Primary Cancer Origin]Factor Value [BM Cancer Specific Subtypes]Days to Last Follow-up or DeathOverall Survival StatusAssay NameRaw or Derived Data File [IDAT file 1]Raw or Derived Data File [IDAT file 2]Data RepositoryData Record Accession [GEO Serie]Data Record Accession
BCBM-01Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis43FemaleBreast CancerHER2 positive/HR any3179DeadIllumina Infinium 450K Human DNA methylation Beadchip200397860045_R06C02_Grn.idat200397860045_R06C02_Red.idatGene Expression OmnibusGSE108576GSM2905348
BCBM-02Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis51FemaleBreast CancerHER2 positive/HR any1296DeadIllumina Infinium 450K Human DNA methylation Beadchip200770460177_R01C01_Grn.idat200770460177_R01C01_Red.idatGene Expression OmnibusGSE108576GSM2905349
BCBM-03Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis52FemaleBreast CancerHormone receptor positive/HER2 negative6849AliveIllumina Infinium 450K Human DNA methylation Beadchip200123460166_R06C01_Grn.idat200123460166_R06C01_Red.idatGene Expression OmnibusGSE108576GSM2905350
BCBM-04Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis52FemaleBreast CancerHormone receptor positive/HER2 negative6849AliveIllumina Infinium 450K Human DNA methylation Beadchip200123460166_R01C02_Grn.idat200123460166_R01C02_Red.idatGene Expression OmnibusGSE108576GSM2905351
BCBM-05Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis53FemaleBreast CancerHER2 positive/HR any1529AliveIllumina Infinium 450K Human DNA methylation Beadchip200397860045_R02C02_Grn.idat200397860045_R02C02_Red.idatGene Expression OmnibusGSE108576GSM2905352
BCBM-06Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis62FemaleBreast CancerHER2 positive/HR any5643AliveIllumina Infinium 450K Human DNA methylation Beadchip200770460177_R02C01_Grn.idat200770460177_R02C01_Red.idatGene Expression OmnibusGSE108576GSM2905353
BCBM-07Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis79FemaleBreast CancerTriple Negative Breast Cancer1328DeadIllumina Infinium 450K Human DNA methylation Beadchip200397860045_R05C02_Grn.idat200397860045_R05C02_Red.idatGene Expression OmnibusGSE108576GSM2905354
BCBM-08Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis50FemaleBreast CancerHER2 positive/HR any4777AliveIllumina Infinium 450K Human DNA methylation Beadchip200123460166_R02C02_Grn.idat200123460166_R02C02_Red.idatGene Expression OmnibusGSE108576GSM2905355
BCBM-09Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis73FemaleBreast CancerTriple Negative Breast Cancer18240AliveIllumina Infinium 450K Human DNA methylation Beadchip200123460166_R03C02_Grn.idat200123460166_R03C02_Red.idatGene Expression OmnibusGSE108576GSM2905356
BCBM-10Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis77FemaleBreast CancerHormone receptor positive/HER2 negative1324DeadIllumina Infinium 450K Human DNA methylation Beadchip200123460166_R01C01_Grn.idat200123460166_R01C01_Red.idatGene Expression OmnibusGSE108576GSM2905357
BCBM-11Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis40FemaleBreast CancerTriple Negative Breast Cancer907AliveIllumina Infinium 450K Human DNA methylation Beadchip200123460166_R02C01_Grn.idat200123460166_R02C01_Red.idatGene Expression OmnibusGSE108576GSM2905358
BCBM-12Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis50FemaleBreast CancerHER2 positive/HR any989AliveIllumina Infinium 450K Human DNA methylation Beadchip200770460041_R02C01_Grn.idat200770460041_R02C01_Red.idatGene Expression OmnibusGSE108576GSM2905359
BCBM-13Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis56FemaleBreast CancerTriple Negative Breast Cancer3724AliveIllumina Infinium 450K Human DNA methylation Beadchip200123460166_R03C01_Grn.idat200123460166_R03C01_Red.idatGene Expression OmnibusGSE108576GSM2905360
BCBM-14Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis44FemaleBreast CancerHormone receptor positive/HER2 negative2075AliveIllumina Infinium 450K Human DNA methylation Beadchip200123460166_R04C01_Grn.idat200123460166_R04C01_Red.idatGene Expression OmnibusGSE108576GSM2905361
BCBM-15Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis65FemaleBreast CancerHormone receptor positive/HER2 negative2511DeadIllumina Infinium 450K Human DNA methylation Beadchip200123460166_R05C01_Grn.idat200123460166_R05C01_Red.idatGene Expression OmnibusGSE108576GSM2905362
BCBM-16Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis72FemaleBreast CancerHormone receptor positive/HER2 negative2239AliveIllumina Infinium 450K Human DNA methylation Beadchip200770460041_R01C01_Grn.idat200770460041_R01C01_Red.idatGene Expression OmnibusGSE108576GSM2905363
BCBM-17Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis40FemaleBreast CancerHormone receptor positive/HER2 negative1303AliveIllumina Infinium 450K Human DNA methylation Beadchip200770460041_R03C01_Grn.idat200770460041_R03C01_Red.idatGene Expression OmnibusGSE108576GSM2905364
BCBM-19Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis53FemaleBreast CancerHER2 positive/HR any1529AliveIllumina Infinium 450K Human DNA methylation Beadchip200397860045_R03C02_Grn.idat200397860045_R03C02_Red.idatGene Expression OmnibusGSE108576GSM2905365
BCBM-20Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis57FemaleBreast CancerHER2 positive/HR any1084DeadIllumina Infinium 450K Human DNA methylation Beadchip200770460180_R01C01_Grn.idat200770460180_R01C01_Red.idatGene Expression OmnibusGSE108576GSM2905366
BCBM-21Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis46FemaleBreast CancerHormone receptor positive/HER2 negative1905AliveIllumina Infinium 450K Human DNA methylation Beadchip200770460180_R02C01_Grn.idat200770460180_R02C01_Red.idatGene Expression OmnibusGSE108576GSM2905367
BCBM-22Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis69FemaleBreast CancerHormone receptor positive/HER2 negative4554DeadIllumina Infinium 450K Human DNA methylation Beadchip200770460180_R03C01_Grn.idat200770460180_R03C01_Red.idatGene Expression OmnibusGSE108576GSM2905368
BCBM-23Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis46FemaleBreast CancerHormone receptor positive/HER2 negative4357DeadIllumina Infinium 450K Human DNA methylation Beadchip200770460180_R04C01_Grn.idat200770460180_R04C01_Red.idatGene Expression OmnibusGSE108576GSM2905369
BCBM-24Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis71FemaleBreast CancerHER2 positive/HR any4737AliveIllumina Infinium 450K Human DNA methylation Beadchip200770460180_R05C01_Grn.idat200770460180_R05C01_Red.idatGene Expression OmnibusGSE108576GSM2905370
BCBM-25Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis67FemaleBreast CancerHormone receptor positive/HER2 negative5125AliveIllumina Infinium 450K Human DNA methylation Beadchip200770460180_R06C01_Grn.idat200770460180_R06C01_Red.idatGene Expression OmnibusGSE108576GSM2905371
BCBM-26Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis57FemaleBreast CancerTriple Negative Breast Cancer1883AliveIllumina Infinium 450K Human DNA methylation Beadchip200770460180_R01C02_Grn.idat200770460180_R01C02_Red.idatGene Expression OmnibusGSE108576GSM2905372
BCBM-27Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis61FemaleBreast CancerHormone receptor positive/HER2 negative9131DeadIllumina Infinium 450K Human DNA methylation Beadchip200770460180_R02C02_Grn.idat200770460180_R02C02_Red.idatGene Expression OmnibusGSE108576GSM2905373
BCBM-28Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis65FemaleBreast CancerHormone receptor positive/HER2 negative9131DeadIllumina Infinium 450K Human DNA methylation Beadchip200770460180_R03C02_Grn.idat200770460180_R03C02_Red.idatGene Expression OmnibusGSE108576GSM2905374
BCBM-31Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis35FemaleBreast CancerHER2 positive/HR anyN/AN/AIllumina Infinium 450K Human DNA methylation Beadchip200770460180_R06C02_Grn.idat200770460180_R06C02_Red.idatGene Expression OmnibusGSE108576GSM2905375
BCBM-32Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis45FemaleBreast CancerHER2 positive/HR anyN/AN/AIllumina Infinium 450K Human DNA methylation Beadchip201031670094_R04C01_Grn.idat201031670094_R04C01_Red.idatGene Expression OmnibusGSE108576GSM2905376
BCBM-33Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis40FemaleBreast CancerHER2 positive/HR any935AliveIllumina Infinium 450K Human DNA methylation Beadchip200770460177_R03C01_Grn.idat200770460177_R03C01_Red.idatGene Expression OmnibusGSE108576GSM2905377
BM-01Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis58FemaleLung CancerNon-Small Cell Lung Cancer1642DeadIllumina Infinium 450K Human DNA methylation Beadchip200770460180_R04C02_Grn.idat200770460180_R04C02_Red.idatGene Expression OmnibusGSE108576GSM2905378
BM-02Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis68FemaleLung CancerNon-Small Cell Lung CancerN/AN/AIllumina Infinium 450K Human DNA methylation Beadchip200770460180_R05C02_Grn.idat200770460180_R05C02_Red.idatGene Expression OmnibusGSE108576GSM2905379
BM-03Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis80FemaleLung CancerNon-Small Cell Lung Cancer1752AliveIllumina Infinium 450K Human DNA methylation Beadchip200866140110_R01C01_Grn.idat200866140110_R01C01_Red.idatGene Expression OmnibusGSE108576GSM2905380
BM-04Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis55FemaleLung CancerNon-Small Cell Lung Cancer736AliveIllumina Infinium 450K Human DNA methylation Beadchip200770460177_R03C02_Grn.idat200770460177_R03C02_Red.idatGene Expression OmnibusGSE108576GSM2905381
LCBM-01Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis62FemaleLung CancerNon-Small Cell Lung Cancer1551DeadIllumina Infinium 450K Human DNA methylation Beadchip200770460177_R04C01_Grn.idat200770460177_R04C01_Red.idatGene Expression OmnibusGSE108576GSM2905382
LCBM-02Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis65FemaleLung CancerNon-Small Cell Lung Cancer1074DeadIllumina Infinium 450K Human DNA methylation Beadchip200770460177_R05C01_Grn.idat200770460177_R05C01_Red.idatGene Expression OmnibusGSE108576GSM2905383
LCBM-03Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis74FemaleLung CancerNon-Small Cell Lung Cancer703AliveIllumina Infinium 450K Human DNA methylation Beadchip200770460177_R06C01_Grn.idat200770460177_R06C01_Red.idatGene Expression OmnibusGSE108576GSM2905384
LCBM-04Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis71FemaleLung CancerNon-Small Cell Lung Cancer137AliveIllumina Infinium 450K Human DNA methylation Beadchip200770460177_R01C02_Grn.idat200770460177_R01C02_Red.idatGene Expression OmnibusGSE108576GSM2905385
LCBM-06Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis67FemaleLung CancerNon-Small Cell Lung Cancer328AliveIllumina Infinium 450K Human DNA methylation Beadchip200770460177_R02C02_Grn.idat200770460177_R02C02_Red.idatGene Expression OmnibusGSE108576GSM2905386
LCBM-08Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis66FemaleLung CancerNon-Small Cell Lung Cancer18DeadIllumina Infinium 450K Human DNA methylation Beadchip200770460177_R04C02_Grn.idat200770460177_R04C02_Red.idatGene Expression OmnibusGSE108576GSM2905387
LCBM-09Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis63FemaleLung CancerNon-Small Cell Lung Cancer1146AliveIllumina Infinium 450K Human DNA methylation Beadchip200770460177_R05C02_Grn.idat200770460177_R05C02_Red.idatGene Expression OmnibusGSE108576GSM2905388
LCBM-10Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis71FemaleLung CancerSmall Cell Lung Cancer583AliveIllumina Infinium 450K Human DNA methylation Beadchip200770460177_R06C02_Grn.idat200770460177_R06C02_Red.idatGene Expression OmnibusGSE108576GSM2905389
LCBM-12Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis86FemaleLung CancerNon-Small Cell Lung Cancer360DeadIllumina Infinium 450K Human DNA methylation Beadchip200866140110_R02C01_Grn.idat200866140110_R02C01_Red.idatGene Expression OmnibusGSE108576GSM2905390
LCBM-14Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis67MaleLung CancerSmall Cell Lung Cancer1050AliveIllumina Infinium 450K Human DNA methylation Beadchip200866140110_R03C01_Grn.idat200866140110_R03C01_Red.idatGene Expression OmnibusGSE108576GSM2905391
LCBM-15Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis88MaleLung CancerNon-Small Cell Lung Cancer623DeadIllumina Infinium 450K Human DNA methylation Beadchip200866140110_R04C01_Grn.idat200866140110_R04C01_Red.idatGene Expression OmnibusGSE108576GSM2905392
LCBM-16Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis69FemaleLung CancerNon-Small Cell Lung Cancer519AliveIllumina Infinium 450K Human DNA methylation Beadchip200866140110_R05C01_Grn.idat200866140110_R05C01_Red.idatGene Expression OmnibusGSE108576GSM2905393
LCBM-17Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis64FemaleLung CancerNon-Small Cell Lung Cancer129DeadIllumina Infinium 450K Human DNA methylation Beadchip200866140110_R06C01_Grn.idat200866140110_R06C01_Red.idatGene Expression OmnibusGSE108576GSM2905394
LCBM-18Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis61MaleLung CancerNon-Small Cell Lung Cancer277DeadIllumina Infinium 450K Human DNA methylation Beadchip200866140110_R01C02_Grn.idat200866140110_R01C02_Red.idatGene Expression OmnibusGSE108576GSM2905395
LCBM-19Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis83FemaleLung CancerNon-Small Cell Lung Cancer975DeadIllumina Infinium 450K Human DNA methylation Beadchip200866140110_R02C02_Grn.idat200866140110_R02C02_Red.idatGene Expression OmnibusGSE108576GSM2905396
LCBM-20Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis43MaleLung CancerSmall Cell Lung Cancer315AliveIllumina Infinium 450K Human DNA methylation Beadchip200866140110_R03C02_Grn.idat200866140110_R03C02_Red.idatGene Expression OmnibusGSE108576GSM2905397
LCBM-21Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis76FemaleLung CancerNon-Small Cell Lung Cancer66DeadIllumina Infinium 450K Human DNA methylation Beadchip200866140110_R04C02_Grn.idat200866140110_R04C02_Red.idatGene Expression OmnibusGSE108576GSM2905398
LCBM-22Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis68FemaleLung CancerNon-Small Cell Lung Cancer11AliveIllumina Infinium 450K Human DNA methylation Beadchip200866140110_R05C02_Grn.idat200866140110_R05C02_Red.idatGene Expression OmnibusGSE108576GSM2905399
MBM-09Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis60MaleMelanomaNRAS mutated2995DeadIllumina Infinium 450K Human DNA methylation Beadchip7310440033_R04C01_Grn.idat7310440033_R04C01_Red.idatGene Expression OmnibusGSE44661GSM1088546
MBM-10Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis63FemaleMelanomaBRAF/NRAS wild type5999DeadIllumina Infinium 450K Human DNA methylation Beadchip7310440033_R05C01_Grn.idat7310440033_R05C01_Red.idatGene Expression OmnibusGSE44661GSM1088547
MBM-11Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis80MaleMelanomaN/A1461AliveIllumina Infinium 450K Human DNA methylation Beadchip7786915145_R06C02_Grn.idat7786915145_R06C02_Red.idatGene Expression OmnibusGSE44661GSM1088548
MBM-12Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis44MaleMelanomaNRAS mutated760DeadIllumina Infinium 450K Human DNA methylation Beadchip7786923108_R02C01_Grn.idat7786923108_R02C01_Red.idatGene Expression OmnibusGSE44661GSM1088549
MBM-14Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis62MaleMelanomaBRAF mutated943DeadIllumina Infinium 450K Human DNA methylation Beadchip7786923108_R04C01_Grn.idat7786923108_R04C01_Red.idatGene Expression OmnibusGSE44661GSM1088551
MBM-15Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis45FemaleMelanomaNRAS mutated2404AliveIllumina Infinium 450K Human DNA methylation Beadchip7786923108_R05C01_Grn.idat7786923108_R05C01_Red.idatGene Expression OmnibusGSE44661GSM1088552
MBM-16Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis48FemaleMelanomaBRAF mutated1232AliveIllumina Infinium 450K Human DNA methylation Beadchip7786923108_R06C01_Grn.idat7786923108_R06C01_Red.idatGene Expression OmnibusGSE44661GSM1088553
MBM-17Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysisNAFemaleMelanomaBRAF mutated8187DeadIllumina Infinium 450K Human DNA methylation Beadchip200397860098_R02C01_Grn.idat200397860098_R02C01_Red.idatGene Expression OmnibusGSE108576GSM2905400
MBM-18Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis75FemaleMelanomaNRAS mutated3881DeadIllumina Infinium 450K Human DNA methylation Beadchip200123460092_R01C01_Grn.idat200123460092_R01C01_Red.idatGene Expression OmnibusGSE108576GSM2905401
MBM-19Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis56MaleMelanomaBRAF mutated1185DeadIllumina Infinium 450K Human DNA methylation Beadchip200397860045_R05C01_Grn.idat200397860045_R05C01_Red.idatGene Expression OmnibusGSE108576GSM2905402
MBM-20Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis70FemaleMelanomaBRAF/NRAS wild type3710AliveIllumina Infinium 450K Human DNA methylation Beadchip200397860098_R05C01_Grn.idat200397860098_R05C01_Red.idatGene Expression OmnibusGSE108576GSM2905403
MBM-21Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis56FemaleMelanomaBRAF/NRAS wild type2014DeadIllumina Infinium 450K Human DNA methylation Beadchip200866140110_R06C02_Grn.idat200866140110_R06C02_Red.idatGene Expression OmnibusGSE108576GSM2905404
MBM-22Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis53MaleMelanomaNRAS mutated2684DeadIllumina Infinium 450K Human DNA methylation Beadchip200397540080_R05C01_Grn.idat200397540080_R05C01_Red.idatGene Expression OmnibusGSE108576GSM2905405
MBM-23Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis73MaleMelanomaNRAS mutated1187DeadIllumina Infinium 450K Human DNA methylation Beadchip200397540080_R06C02_Grn.idat200397540080_R06C02_Red.idatGene Expression OmnibusGSE108576GSM2905406
MBM-24Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis71MaleMelanomaNRAS mutated2252DeadIllumina Infinium 450K Human DNA methylation Beadchip200397860045_R03C01_Grn.idat200397860045_R03C01_Red.idatGene Expression OmnibusGSE108576GSM2905407
MBM-25Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis51MaleMelanomaBRAF mutated3541DeadIllumina Infinium 450K Human DNA methylation Beadchip200397540080_R01C02_Grn.idat200397540080_R01C02_Red.idatGene Expression OmnibusGSE108576GSM2905408
MBM-26Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis75MaleMelanomaNRAS mutated2078DeadIllumina Infinium 450K Human DNA methylation Beadchip200397860098_R03C02_Grn.idat200397860098_R03C02_Red.idatGene Expression OmnibusGSE108576GSM2905409
MBM-27Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis82MaleMelanomaBRAF mutated4217DeadIllumina Infinium 450K Human DNA methylation Beadchip200397540080_R04C02_Grn.idat200397540080_R04C02_Red.idatGene Expression OmnibusGSE108576GSM2905410
MBM-28Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis47MaleMelanomaBRAF mutated4867AliveIllumina Infinium 450K Human DNA methylation Beadchip200397540080_R03C02_Grn.idat200397540080_R03C02_Red.idatGene Expression OmnibusGSE108576GSM2905411
MBM-29Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis74MaleMelanomaNRAS mutated209DeadIllumina Infinium 450K Human DNA methylation Beadchip201031670094_R01C02_Grn.idat201031670094_R01C02_Red.idatGene Expression OmnibusGSE108576GSM2905412
MBM-30Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis64MaleMelanomaBRAF/NRAS wild type1296AliveIllumina Infinium 450K Human DNA methylation Beadchip201031670094_R02C02_Grn.idat201031670094_R02C02_Red.idatGene Expression OmnibusGSE108576GSM2905413
MBM-31Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis72MaleMelanomaNRAS mutated2465DeadIllumina Infinium 450K Human DNA methylation Beadchip200397860045_R04C01_Grn.idat200397860045_R04C01_Red.idatGene Expression OmnibusGSE108576GSM2905414
MBM-32Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis46FemaleMelanomaBRAF mutated3207DeadIllumina Infinium 450K Human DNA methylation Beadchip200397540080_R02C02_Grn.idat200397540080_R02C02_Red.idatGene Expression OmnibusGSE108576GSM2905415
MBM-33Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis53MaleMelanomaBRAF mutated654DeadIllumina Infinium 450K Human DNA methylation Beadchip200397860045_R01C02_Grn.idat200397860045_R01C02_Red.idatGene Expression OmnibusGSE108576GSM2905416
MBM-34Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis55MaleMelanomaNRAS mutated1152DeadIllumina Infinium 450K Human DNA methylation Beadchip200397860045_R06C01_Grn.idat200397860045_R06C01_Red.idatGene Expression OmnibusGSE108576GSM2905417
MBM-35Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis62MaleMelanomaBRAF mutated1000DeadIllumina Infinium 450K Human DNA methylation Beadchip200397540080_R01C01_Grn.idat200397540080_R01C01_Red.idatGene Expression OmnibusGSE108576GSM2905418
MBM-36Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis40MaleMelanomaBRAF mutated6684AliveIllumina Infinium 450K Human DNA methylation Beadchip200397540080_R03C01_Grn.idat200397540080_R03C01_Red.idatGene Expression OmnibusGSE108576GSM2905419
MBM-37Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis58MaleMelanomaNRAS mutated1383DeadIllumina Infinium 450K Human DNA methylation Beadchip200397540080_R06C01_Grn.idat200397540080_R06C01_Red.idatGene Expression OmnibusGSE108576GSM2905420
MBM-38Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis49FemaleMelanomaBRAF mutated6658AliveIllumina Infinium 450K Human DNA methylation Beadchip200397540080_R04C01_Grn.idat200397540080_R04C01_Red.idatGene Expression OmnibusGSE108576GSM2905421
MBM-39Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis64MaleMelanomaBRAF mutated1713DeadIllumina Infinium 450K Human DNA methylation Beadchip9305216131_R06C02_Grn.idat9305216131_R06C02_Red.idatGene Expression OmnibusGSE108576GSM2905422
MBM-40Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis55MaleMelanomaNRAS mutated555DeadIllumina Infinium 450K Human DNA methylation Beadchip200397540080_R02C01_Grn.idat200397540080_R02C01_Red.idatGene Expression OmnibusGSE108576GSM2905423
MBM-41Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis62FemaleMelanomaNRAS mutated119DeadIllumina Infinium 450K Human DNA methylation Beadchip200397540080_R05C02_Grn.idat200397540080_R05C02_Red.idatGene Expression OmnibusGSE108576GSM2905424
MBM-42Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis32MaleMelanomaBRAF mutated5648DeadIllumina Infinium 450K Human DNA methylation Beadchip9305216131_R05C02_Grn.idat9305216131_R05C02_Red.idatGene Expression OmnibusGSE108576GSM2905425
MBM-43Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis48MaleMelanomaNRAS mutated1895DeadIllumina Infinium 450K Human DNA methylation Beadchip200397860098_R05C02_Grn.idat200397860098_R05C02_Red.idatGene Expression OmnibusGSE108576GSM2905426
MBM-44Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis72MaleMelanomaBRAF mutated1810DeadIllumina Infinium 450K Human DNA methylation Beadchip9305216131_R04C02_Grn.idat9305216131_R04C02_Red.idatGene Expression OmnibusGSE108576GSM2905427
MBM-45Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis42FemaleMelanomaBRAF mutated919DeadIllumina Infinium 450K Human DNA methylation Beadchip200397860045_R02C01_Grn.idat200397860045_R02C01_Red.idatGene Expression OmnibusGSE108576GSM2905428
MBM-46Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis80MaleMelanomaBRAF mutated1716DeadIllumina Infinium 450K Human DNA methylation Beadchip8784241079_R04C01_Grn.idat8784241079_R04C01_Red.idatGene Expression OmnibusGSE108576GSM2905429
MBM-47Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis59MaleMelanomaBRAF mutated1271DeadIllumina Infinium 450K Human DNA methylation Beadchip7800246021_R03C01_Grn.idat7800246021_R03C01_Red.idatGene Expression OmnibusGSE108576GSM2905430
MBM-48Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis56FemaleMelanomaNRAS mutated3471DeadIllumina Infinium 450K Human DNA methylation Beadchip7310440033_R03C01_Grn.idat7310440033_R03C01_Red.idatGene Expression OmnibusGSE108576GSM2905431
MBM-49Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis54MaleMelanomaNRAS mutated1926DeadIllumina Infinium 450K Human DNA methylation Beadchip7800246020_R01C01_Grn.idat7800246020_R01C01_Red.idatGene Expression OmnibusGSE108576GSM2905432
MBM-50Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis44MaleMelanomaBRAF mutated1688DeadIllumina Infinium 450K Human DNA methylation Beadchip200397860045_R01C01_Grn.idat200397860045_R01C01_Red.idatGene Expression OmnibusGSE108576GSM2905433
MBM-51Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis77MaleMelanomaN/A514DeadIllumina Infinium 450K Human DNA methylation Beadchip8784241079_R03C01_Grn.idat8784241079_R03C01_Red.idatGene Expression OmnibusGSE108576GSM2905434
MBM-52Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis73MaleMelanomaBRAF/NRAS wild type904DeadIllumina Infinium 450K Human DNA methylation Beadchip7800246021_R01C01_Grn.idat7800246021_R01C01_Red.idatGene Expression OmnibusGSE108576GSM2905435
MBM-53Patient with brain metastasisHomo sapiensBrain metastasisMicrodissected formalin-fixed paraffin-embedded tissueTissue specimen collectionHistopathological classification of brain metastasisGenomic DNA extractionGenome-wide DNA methylation profilingData processing and analysis54MaleMelanomaNRAS mutated3719DeadIllumina Infinium 450K Human DNA methylation Beadchip7800246021_R02C01_Grn.idat7800246021_R02C01_Red.idatGene Expression OmnibusGSE108576GSM2905436
The LCBM were histologically classified into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC; Table 1). Of note, we added four BM specimens from female patients with a presumptive diagnosis of LCBM, but with inconclusive IHC analysis, or with a previous diagnosis of both primary lung and breast cancer. In agreement with the clinical-pathological diagnosis an origin of lung cancer was confirmed by DNAm profiling[21].

Genomic DNA extraction

Representative FFPE tissue blocks from each metastatic brain lesion were selected by the respective Pathology Departments. FFPE tissue blocks were cut into 4 μm and 8 μm serial slides. Neuropathologists reviewed 4 μm tissue slides stained with hematoxylin & eosin (H&E) for all specimens and labeled representative brain metastatic areas with an estimated tumor purity higher than 70%. After deparaffinization, hematoxylin staining was performed in 8 μm thick serial tissue sections and needle microdissected using the labeled 4 μm tissue slides as template. Genomic DNA (gDNA) was then isolated using ZR FFPE DNA MiniPrep (D3066; Zymo Research, Irvine, CA, USA), according to the manufacturer’s instructions. Genomic DNA was quantified by Qubit® 3.0 Fluorometer (Q33216; Thermo Fisher Scientific, Carlsbad, CA).

Genome-wide DNA methylation profiling

Sodium bisulfite modification (SBM) was performed on 1 μg of gDNA using the EZ DNA Methylation-Direct Kit (D5021, Zymo Research Irvine, CA, USA). An aliquot of SBM-DNA was analyzed by MethyLight-based quality control to test bisulfite completeness. After correction of SBM-DNA amount, a minimum of 200 ng of SBM-DNA was whole-genome amplified and enzymatically fragmented. Finally, the fragmented SBM-DNA was hybridized into the HM450K (Illumina Inc., San Diego, CA, USA) and scanned using the Illumina iScan microarray scanner following the manufacturer’s recommended settings (Illumina Inc., San Diego, CA, USA).

Data processing and analysis

Data was extracted from Illumina .idat files using the Bioconductor package minfi[25]. The ‘preprocessNoob’ function in minfi was used for normalization and dye-bias correction as described in Triche et al.[26]. DNAm levels were reported as β-values [β = intensity of the methylated allele/(intensity of the unmethylated allele + intensity of the methylated allele)], and calculated using the signal intensity value for each CpG site. The effect of normalization on the distribution of β values across samples is shown in Fig. 2.
Figure 2

Density distribution of β values across samples.

(a) The distribution of raw β values for all three BM subtypes before normalization. (b) The distribution of β values after normalization for all three BM subtypes. BM subtype is indicated by the color of the line, with green lines representing breast cancer brain metastases (BCBM), orange lines representing lung cancer brain metastases (LCBM), and purple lines representing melanoma brain metastases (MBM).

Using the normalized β values, we compared the genome-wide DNAm profiles for specific genomic features across the three BM groups. DNAm level of CpG sites in high-CpG density regions (known as CpG islands; CGI) and low-CpG density regions (known as CGI shore, CGI shelves, and open sea) were also variable among the three BM groups (Fig. 3a). Additionally, DNAm levels varied among the three BM groups for CpG sites in the promoter regions, 5’UTRs, the first exon, gene body, and intergenic regions (IGRs; Fig. 3b). Finally, to check for overall structure within our dataset, we used the t-distributed stochastic neighbor embedding (t-SNE)[27,28] method with the top 2,500 most variable HM450K probes to cluster all BM specimens. Three distinct clusters were observed that corresponded to each of the three BM types, with MBMs showing the greatest degree of separation from BCBM and LCBM which were positioned more closely to each other (Fig. 3c). No outlier samples were observed.
Figure 3

Distribution of β values among genomic features and BM type specific clustering.

(a) The distribution of DNAm levels in low-CpG density regions (i.e. open sea, CGI shelf, and CGI shore) with respect to high-CpG density CGIs. (b) The distribution of DNAm levels for CpG sites with respect to gene compartments in the promoter regions, 5’UTRs, the 1st exon, gene body, and intergenic regions (IGRs). Box colors indicate BM subtype, with green boxes representing breast cancer brain metastases (BCBM), orange boxes representing lung cancer brain metastases (LCBM), and purple boxes representing melanoma brain metastases (MBM). (c) t-SNE analysis reveals BM subtype specific clustering of samples. The top 2,500 most variable CpG sites were used for the analysis with the first two dimensions shown. Each of the three BM subtypes is confined to a cluster, with MBMs depicted in purple, BCBMs depicted in green, and LCBMs depicted in orange. No samples were found to fall outside of a BM subtype specific cluster

Code availability

All analyses were performed using open source R and Bioconductor packages. Specifically, the minfi[25] package was used to process raw array data and perform normalizations (see “Data processing and analysis” section), summary statistics were calculated using functions in base R and the matrixStats[29] package, density distribution plots were generated using the densityPlot function in minfi[25], all other figures were generated using the ggplot2[30] and RColorBrewer[31] packages, and the t-SNE analysis was performed using the Rtsne[32]package. No custom code was used in the processing or analysis of this data.

Data Records

All HM450K raw and normalized data that support the findings of this study have been deposited in the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO; https://www.ncbi.nlm.nih.gov/geo/) datasets under the series records GSE108576 (Data Citation 1) and GSE44661 (Data Citation 2). The data is presented in a tabular format that includes the unmethylated intensity values, the methylated intensity values, the p-value from the statistical evaluation of the differences between signal and noise, and the corrected β value. The DNAm data can also be accessed as raw intensity files (.idat). Additionally, the integration of the clinical-demographic characteristics of the 96 BM specimens with the matched .idat file names and the GEO sample identifiers (GSM) is provided in Table 2 (available online only).

Technical Validation

To ensure that only samples with high overall quality were included in this dataset, we applied a three-step quality control pipeline: 1) We filtered samples by probe detection p-value to identify samples with an elevated level of background noise. A significance level of 0.05 for the mean per sample detection p-value was used as a cut-off. All 96 samples included in this dataset showed mean detection p-values less than 0.05 (Fig. 4a). 2) We calculated the number of probes with missing β values per sample. Across all 96 samples, the median number of probes with missing β values was 7.0 probes per sample with a range of 1 to 246 probes (Fig. 4b). Overall, the number of probes with missing β values represents a minuscule fraction of the total number of probes present on the array and therefore is highly unlikely to have an adverse effect on downstream analysis. 3) For each probe, we calculated the number of samples with missing β values. Notably, of the 485,577 probes included on the HM450K microarray, probe cg01550828 showed missing β values in 79 samples (Fig. 4c). Probe cg01550828 is located in the body of the ring finger protein 168 (RNF168) gene and is one of five probes within the RNF168 gene body. While cg01550828 showed missing values, none of the other four RNF168 gene body probes showed any missing values across the 96 samples.
Figure 4

Quality metrics used for sample filtering. A three-part quality control pipeline was used to identify samples with low quality.

(a) The distribution of mean detection p-values for all probes in each sample. (b) The distribution of the number of probes with missing data per sample. (c) The distribution of the top 25 probes with missing data. For panels a and b, colors represented BM subtype with green bars representing breast cancer brain metastases (BCBM), orange bars representing lung cancer brain metastases (LCBM), and purple bars representing melanoma brain metastases (MBM).

Usage Notes

To enhance the utility of this resource, we have integrated the most relevant clinical and demographic features of the patient cohort and DNAm data for each BM specimen. In Table 2 (available online only), we included patient age at BM diagnosis, gender, primary cancer of origin, and cancer-specific subtypes matched with GEO sample names and .idat identifiers. This information can be accessed from the respective GEO series GSE108576 (Data Citation 1) and GSE44661 (Data Citation 2). The dataset we present here can be further analyzed to study the differential methylation profiles among the three BM groups described here and/or integrated into larger methylation analyses using new or existing publicly available array data deposited in GEO. Data normalization and differential methylation analysis can be performed using various open source Bioconductor packages. In particular, the ChAMP Bioconductor package provides a comprehensive analysis pipeline that utilizes many well-established methods for the normalization and analysis of Illumina HM450K microarray data[33]. This package is well documented and provides a useful first pass pipeline for processing array data.

Additional information

How to cite this article: Salomon, M. P. et al. Brain metastasis DNA methylomes, a novel resource for the identification of biological and clinical features. Sci. Data. 5:180245 doi: 10.1038/sdata.2018.245 (2018). Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
  26 in total

1.  DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.

Authors:  Felix Sahm; Daniel Schrimpf; Damian Stichel; David T W Jones; Thomas Hielscher; Sebastian Schefzyk; Konstantin Okonechnikov; Christian Koelsche; David E Reuss; David Capper; Dominik Sturm; Hans-Georg Wirsching; Anna Sophie Berghoff; Peter Baumgarten; Annekathrin Kratz; Kristin Huang; Annika K Wefers; Volker Hovestadt; Martin Sill; Hayley P Ellis; Kathreena M Kurian; Ali Fuat Okuducu; Christine Jungk; Katharina Drueschler; Matthias Schick; Melanie Bewerunge-Hudler; Christian Mawrin; Marcel Seiz-Rosenhagen; Ralf Ketter; Matthias Simon; Manfred Westphal; Katrin Lamszus; Albert Becker; Arend Koch; Jens Schittenhelm; Elisabeth J Rushing; V Peter Collins; Stefanie Brehmer; Lukas Chavez; Michael Platten; Daniel Hänggi; Andreas Unterberg; Werner Paulus; Wolfgang Wick; Stefan M Pfister; Michel Mittelbronn; Matthias Preusser; Christel Herold-Mende; Michael Weller; Andreas von Deimling
Journal:  Lancet Oncol       Date:  2017-03-15       Impact factor: 41.316

2.  Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays.

Authors:  Martin J Aryee; Andrew E Jaffe; Hector Corrada-Bravo; Christine Ladd-Acosta; Andrew P Feinberg; Kasper D Hansen; Rafael A Irizarry
Journal:  Bioinformatics       Date:  2014-01-28       Impact factor: 6.937

Review 3.  Brain metastases: epidemiology and pathophysiology.

Authors:  Igor T Gavrilovic; Jerome B Posner
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

4.  Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis.

Authors:  Sebastian Moran; Anna Martínez-Cardús; Sergi Sayols; Eva Musulén; Carme Balañá; Anna Estival-Gonzalez; Cátia Moutinho; Holger Heyn; Angel Diaz-Lagares; Manuel Castro de Moura; Giulia M Stella; Paolo M Comoglio; Maria Ruiz-Miró; Xavier Matias-Guiu; Roberto Pazo-Cid; Antonio Antón; Rafael Lopez-Lopez; Gemma Soler; Federico Longo; Isabel Guerra; Sara Fernandez; Yassen Assenov; Christoph Plass; Rafael Morales; Joan Carles; David Bowtell; Linda Mileshkin; Daniela Sia; Richard Tothill; Josep Tabernero; Josep M Llovet; Manel Esteller
Journal:  Lancet Oncol       Date:  2016-08-27       Impact factor: 41.316

5.  Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.

Authors:  Jill S Barnholtz-Sloan; Andrew E Sloan; Faith G Davis; Fawn D Vigneau; Ping Lai; Raymond E Sawaya
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

6.  DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations.

Authors:  Diego M Marzese; Richard A Scolyer; Maria Roqué; Laura M Vargas-Roig; Jamie L Huynh; James S Wilmott; Rajmohan Murali; Michael E Buckland; Garni Barkhoudarian; John F Thompson; Donald L Morton; Daniel F Kelly; Dave S B Hoon
Journal:  Neuro Oncol       Date:  2014-06-26       Impact factor: 12.300

7.  Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome.

Authors:  Diego M Marzese; Michelle Liu; Jamie L Huynh; Hajime Hirose; Nicholas C Donovan; Kelly T Huynh; Eiji Kiyohara; Kelly Chong; David Cheng; Ryo Tanaka; Jinhua Wang; Donald L Morton; Garni Barkhoudarian; Daniel F Kelly; Dave S B Hoon
Journal:  Pigment Cell Melanoma Res       Date:  2014-09-30       Impact factor: 4.693

8.  Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.

Authors:  Michele Ceccarelli; Floris P Barthel; Tathiane M Malta; Thais S Sabedot; Sofie R Salama; Bradley A Murray; Olena Morozova; Yulia Newton; Amie Radenbaugh; Stefano M Pagnotta; Samreen Anjum; Jiguang Wang; Ganiraju Manyam; Pietro Zoppoli; Shiyun Ling; Arjun A Rao; Mia Grifford; Andrew D Cherniack; Hailei Zhang; Laila Poisson; Carlos Gilberto Carlotti; Daniela Pretti da Cunha Tirapelli; Arvind Rao; Tom Mikkelsen; Ching C Lau; W K Alfred Yung; Raul Rabadan; Jason Huse; Daniel J Brat; Norman L Lehman; Jill S Barnholtz-Sloan; Siyuan Zheng; Kenneth Hess; Ganesh Rao; Matthew Meyerson; Rameen Beroukhim; Lee Cooper; Rehan Akbani; Margaret Wrensch; David Haussler; Kenneth D Aldape; Peter W Laird; David H Gutmann; Houtan Noushmehr; Antonio Iavarone; Roel G W Verhaak
Journal:  Cell       Date:  2016-01-28       Impact factor: 41.582

9.  Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers.

Authors:  Anna S Berghoff; Sophie Schur; Lisa M Füreder; Brigitte Gatterbauer; Karin Dieckmann; Georg Widhalm; Johannes Hainfellner; Christoph C Zielinski; Peter Birner; Rupert Bartsch; Matthias Preusser
Journal:  ESMO Open       Date:  2016-03-16

10.  COSMIC: somatic cancer genetics at high-resolution.

Authors:  Simon A Forbes; David Beare; Harry Boutselakis; Sally Bamford; Nidhi Bindal; John Tate; Charlotte G Cole; Sari Ward; Elisabeth Dawson; Laura Ponting; Raymund Stefancsik; Bhavana Harsha; Chai Yin Kok; Mingming Jia; Harry Jubb; Zbyslaw Sondka; Sam Thompson; Tisham De; Peter J Campbell
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

View more
  9 in total

1.  Human methylome variation across Infinium 450K data on the Gene Expression Omnibus.

Authors:  Sean K Maden; Reid F Thompson; Kasper D Hansen; Abhinav Nellore
Journal:  NAR Genom Bioinform       Date:  2021-04-22

2.  Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon.

Authors:  Emilie Darrigues; Benjamin W Elberson; Annick De Loose; Madison P Lee; Ebonye Green; Ashley M Benton; Ladye G Sink; Hayden Scott; Murat Gokden; John D Day; Analiz Rodriguez
Journal:  Front Oncol       Date:  2021-04-26       Impact factor: 6.244

3.  A database for using machine learning and data mining techniques for coronary artery disease diagnosis.

Authors:  R Alizadehsani; M Roshanzamir; M Abdar; A Beykikhoshk; A Khosravi; M Panahiazar; A Koohestani; F Khozeimeh; S Nahavandi; N Sarrafzadegan
Journal:  Sci Data       Date:  2019-10-23       Impact factor: 6.444

4.  Development of a hoRizontal data intEgration classifier for NOn-invasive early diAgnosis of breasT cancEr: the RENOVATE study protocol.

Authors:  Alberto Tagliafico; Lorenzo Ferrando; Gabriele Zoppoli; Francesco Ravera; Gabriella Cirmena; Martina Dameri; Maurizio Gallo; Valerio Gaetano Vellone; Piero Fregatti; Daniele Friedman; Massimo Calabrese; Alberto Ballestrero
Journal:  BMJ Open       Date:  2021-12-31       Impact factor: 2.692

5.  Circular RNA circBCBM1 promotes breast cancer brain metastasis by modulating miR-125a/BRD4 axis.

Authors:  Bo Fu; Wei Liu; Cui Zhu; Peng Li; Li Wang; Li Pan; Ke Li; Peiying Cai; Min Meng; Yiting Wang; Anqi Zhang; Wenqiang Tang; Meng An
Journal:  Int J Biol Sci       Date:  2021-07-22       Impact factor: 6.580

Review 6.  Clinical Biomarkers for Early Identification of Patients with Intracranial Metastatic Disease.

Authors:  Karolina Gaebe; Alyssa Y Li; Sunit Das
Journal:  Cancers (Basel)       Date:  2021-11-27       Impact factor: 6.639

7.  Genomic and Transcriptomic Profiling of Brain Metastases.

Authors:  Christopher P Wardell; Emilie Darrigues; Annick De Loose; Madison P Lee; Murat Gokden; Issam Makhoul; Alan J Tackett; Analiz Rodriguez
Journal:  Cancers (Basel)       Date:  2021-11-09       Impact factor: 6.639

Review 8.  Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases-From Biology to Clinical Utility.

Authors:  Priyakshi Kalita-de Croft; Vaibhavi Joshi; Jodi M Saunus; Sunil R Lakhani
Journal:  Diseases       Date:  2022-02-03

9.  PKIB involved in the metastasis and survival of osteosarcoma.

Authors:  Rongxue Wan; Gu Yang; Qianzhen Liu; Xiaokang Fu; Zengping Liu; Huilai Miao; Huan Liu; Wenhua Huang
Journal:  Front Oncol       Date:  2022-08-22       Impact factor: 5.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.